Novel EXO-T vaccine using polyclonal CD4+ T cells armed with HER2-specific exosomes for HER2-positive breast cancer

Rong Li,1,2 Rajni Chibbar,3 Jim Xiang1,2 1Cancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, SK, Canada; 2Department of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada; 3Department of Pathology, College of Medicine, University of Saskatchewan, Saskatoon...

Full description

Bibliographic Details
Main Authors: Li R, Chibbar R, Xiang J
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/novel-exo-t-vaccine-using-polyclonal-cd4-t-cells-armed-with-her2-speci-peer-reviewed-article-OTT